SAFEs vs. notes vs. priced rounds
LAST REVIEWED 2026-08 · SOURCED FROM 3 SESSIONS, FEB–MAY 2026
What each instrument actually is
Section titled “What each instrument actually is”A SAFE is an IOU for preferred stock. It is neither debt nor equity — purely a contract. The holder has no stockholder rights, earns no interest, and there is no maturity date. When you close your first priced round, SAFE holders convert into the same preferred stock as the new investors, with the same liquidation preference. That matters: your earliest backers are not left unprotected once conversion happens.
A convertible note is debt. It carries interest (typically 8–12%) and a maturity date. Notes show up two places: very early rounds with old-school investors, and bridge rounds later, where investors want the extra protection debt gives. One hard lesson from the room: in a bankruptcy, secured note holders took the company’s IP while SAFE holders — treated like preferred stockholders — got nothing.
A priced round sells actual preferred stock at a negotiated valuation, with an investor lead, a full document set, and usually a board seat. It is the moment your cap table, governance, and control structure get set for years.
Why the cost gap decides the early rounds
Section titled “Why the cost gap decides the early rounds”A priced round means roughly 200–250 pages of documents and four-plus weeks of work. The company customarily pays the investors’ counsel as well as its own — in the room, the figures quoted were $35–50K for investor counsel and 1.5–2x that for your own side.
“You’re now paying $150K to get a million dollars into the company… probably not the best use of funds.”
— Partner at a top-tier venture law firm, ~19 years of practice · session, Feb 2026
A SAFE round, by contrast: the standard YC form, board approval, an SEC Form D filing. A few thousand dollars, done in days.
The trap: stacking SAFEs without doing the math
Section titled “The trap: stacking SAFEs without doing the math”SAFEs feel free because dilution is invisible until conversion. It isn’t free.
Scale the cap to the raise. $1M on a $10M post-money cap is ~10% dilution — fine. Raising $3M at that same $10M cap hands over 30%; push the cap toward $15M to keep the round near 20%. Founders who stack $5–6M of SAFEs across $10M, $12M, and $15M caps can wake up having sold 35–40% of the company before any priced round happens.
“The longer you can go without raising and increase revenues, the higher valuation you can command, and the less dilution you’ll take long-term.”
— Startup securities attorney, 15 years of practice · session, Mar 2026
Two related mechanics to watch:
- The option pool sits in the conversion denominator. An unused 20% option pool makes every SAFE convert against a bigger share count, and founders eat that dilution. Keep the pool near 10%; increasing it later is trivial.
- Terminology check: a “90% discount rate” in SAFE language means a 10% discount. Founders have drafted the wrong number without knowing which one they meant. Read the YC form’s definitions before you send anything.
When to price the round
Section titled “When to price the round”Around a $3–5M raise, the calculus flips: the legal cost stops being decisive, and lead investors want real preferred stock, information rights, and usually a board seat. Benchmarks quoted in the room, drawing on Carta’s published data: a ~$10M post-money cap is the pre-seed median; a $3M raise on SAFEs implies more like an $18–20M cap. Raising $1.5M at a $6M cap is ~25% dilution — too much.
One more decision that outlasts the round:
“Think about it like a marriage. But maybe even more so, because you can’t unilaterally divorce this investor.”
— Partner at a top-tier venture law firm · session, Feb 2026, on granting a board seat
A seed board seat lasts until the investor sells or agrees to leave. At the SAFE stage, cap concessions at a board observer side letter; save the seat for a priced lead.
Numbers from the room
Section titled “Numbers from the room”| Figure | Value |
|---|---|
| Priced round document set | ~200–250 pages, 4+ weeks |
| Priced round legal cost (both sides, company pays) | ~$100–150K |
| SAFE round legal cost | A few thousand dollars |
| Convertible note interest | 8–12% |
| SPV vs. individual SAFEs | ≤ ~20 investors: individual SAFEs are simpler |
| Pre-seed median post-money cap (Carta data, cited May 2026) | ~$10M |
| Sensible dilution per early round | ~10–20% |
| Raise size where pricing the round makes sense | ~$3–5M |
Watch out for
Section titled “Watch out for”“Fundraising helpers” paid on money raised. Anyone compensated conditionally on investment closing must be a registered broker-dealer — and the company is liable for aiding and abetting. SEC enforcement against companies has increased. Pay advisors for deck work and introductions unconditioned on the money, never a percentage of the round.
Founders lending their own money. Document it — as a SAFE if you want equity, as a simple demand loan if you want the cash back. Undocumented founder cash is a diligence mess later.
Sources
Section titled “Sources”Three sessions: a fireside with a partner at a national venture law firm (Feb 2026), and two working sessions with a startup securities attorney walking founders through SAFE conversion mechanics and dilution modeling (Mar and May 2026). Standard documents referenced: the YC post-money SAFE, SEC Form D, Carta benchmark data.